Share of Cost, New research leads to FDA approval of first drug to treat radiation sickness

Tuesday, Sep. 15th 2015 6:00 AM

New research has led to FDA approval of the use of a drug to treat the effects of radiation exposure following a nuclear incident. The drug, Neupogen, is the first ever approved for the treatment of acute radiation injury.

Posted on Tuesday, Sep. 15th 2015 6:00 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply


Warning: Undefined variable $user_ID in /home/.sites/site55/wwwroot/web/shareofcostblog/wp-content/themes/shareofcostblog/comments.php on line 68

You must be logged in to post a comment.